Expert Review of Anti-Infective Therapy
(ISSN: 1478-7210, 1744-8336)
Show only: Full-text on Medscape
2009 - 7 (7)
- Acknowledgements.
- Orf: an update on current research and future perspectives.
- Novel Helicobacter pylori therapeutic targets: the unusual suspects.
- Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development.
- The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
- Pylera for the eradication of Helicobacter pylori infection.
- Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.
- News in brief.
- Treatment of septic shock and use of drotrecogin alfa (activated) in children.
- Que sera, sera: evolution of the swine H1N1 influenza A virus.